NCT06058156 Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic Dermatitis Status TERMINATED Phase PHASE2
NCT06058000 A Phase 2 Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT06055374 A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis Status WITHDRAWN Phase PHASE1
NCT06055361 A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis Status RECRUITING Phase PHASE1
NCT06039241 Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years With Atopic Dermatitis Status RECRUITING Phase N/A
NCT06035835 Probiotics and Breastmilk Decrease Risk of Atopic Dermatitis in Premature Infants Status COMPLETED Phase N/A
NCT06035354 A Study to Evaluate the Safety, Pharmacokinetics and Efficacy of AK120 in Subjects With Atopic Dermatitis Status COMPLETED Phase PHASE1/PHASE2
NCT06032403 Patient with Atopic Dermatitis' Needs for Self-management Support - Flexible Patient Centred Consultations Status ACTIVE_NOT_RECRUITING Phase NA
NCT06026891 Study of MG-K10 Humanized Monoclonal Antibody Injection in Patients With Atopic Dermatitis Status RECRUITING Phase PHASE3
NCT06024499 Phase 2 Trial of HY209gel in Atopic Dermatitis Patients Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06022874 The Therapeutic Effects of Topical Cannabidiol (CBD) Products for Atopic Dermatitis Status UNKNOWN Phase N/A
NCT06009094 Safety, Tolerance and Pharmacokinetics Clinical Study of VC005 in Healthy Subjects and Patients with Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE1
NCT06005792 Multiple Ascending-Dose Study of XmAb®27564 in Patients With Psoriasis or Atopic Dermatitis Status TERMINATED Phase PHASE1
NCT06004986 DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema Status RECRUITING Phase PHASE4
NCT05995964 A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis Status RECRUITING Phase PHASE2
NCT05994976 Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers Status RECRUITING Phase N/A
NCT05992493 The Role of Human Milk Oligosaccharides and Microbiomes on Infantile Colic and Atopic Dermatitis in Term Infants Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05990725 Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05989932 Real-world Experience on the Use of Upadacitinib in the Treatment of Moderate-severe Adult Atopic Dermatitis (ERUDA) Status COMPLETED Phase N/A
NCT05984784 A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD) Status TERMINATED Phase PHASE1/PHASE2